Thursday, October 12, 2017 6:57:30 PM
From today's news release:
"On September 22, 2017, the Company received labeling comments from the FDA which the Company responded to on September 29, 2017."
My guess is that from this communication, suspicions began to rise at the company.
IF SO, it would seem that this insider trade was border line illegal.
I'm obviously disappointed because the trial results were excellent. They still have other drugs with PDUFAs coming up so I'm not selling. In fact, if it falls significantly tomorrow, I may pick up some more shares.
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM